Table 2.
Tumor types | Non-HPD (n = 339) | HPD (n = 38) | The incidence of HPD | P |
---|---|---|---|---|
Lung cancer | 119 | 14 | 10.53% | |
Pancreatic cancer | 18 | 7 | 28.00% | |
Esophageal cancer | 8 | 2 | 20.00% | |
Colorectal cancer | 17 | 5 | 22.73% | |
Cholangiocarcinoma | 19 | 3 | 13.64% | |
Liver cancer | 15 | 2 | 11.76% | <0.01 |
Lymphoma | 25 | 1 | 3.85% | |
Ampullary carcinoma | 5 | 1 | 16.67% | |
Cervical carcinoma | 6 | 1 | 14.29% | |
Gastric carcinoma | 31 | 2 | 6.06% | |
Other | 76 | 0 | 0.00% |
HPD: hyperprogressive disease.